US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 8.647
  • +0.117+1.37%
Trading Jan 16 11:02 ET
221.50MMarket Cap-6.31P/E (TTM)

Nuvectis Pharma (NVCT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
78.80%7.79M
42.04%6.6M
26.66%5.57M
-13.32%19.85M
-6.07%6.45M
-29.21%4.36M
-19.56%4.64M
7.19%4.4M
19.04%22.9M
1.30%6.87M
Selling and administrative expenses
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
-General and administrative expense
31.17%2.02M
75.41%2.98M
8.76%1.89M
-7.82%6.93M
-24.91%1.95M
-7.89%1.54M
12.58%1.7M
0.12%1.74M
25.14%7.52M
9.24%2.6M
Research and development costs
104.82%5.77M
22.77%3.61M
38.35%3.68M
-16.01%12.92M
5.42%4.5M
-37.16%2.82M
-30.95%2.94M
12.38%2.66M
16.28%15.38M
-3.00%4.27M
Operating profit
-78.80%-7.79M
-42.04%-6.6M
-26.66%-5.57M
13.32%-19.85M
6.07%-6.45M
29.21%-4.36M
19.56%-4.64M
-7.19%-4.4M
-19.04%-22.9M
-1.30%-6.87M
Net non-operating interest income expense
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
Non-operating interest income
61.17%332K
21.40%261K
4.89%236K
32.97%847K
-17.62%201K
-25.63%206K
235.94%215K
332.69%225K
327.52%637K
197.56%244K
Other net income (expense)
Income before tax
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
Income tax
Net income
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
Net income continuous Operations
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
Minority interest income
Net income attributable to the parent company
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
Preferred stock dividends
Other preferred stock dividends
2.43M
0
Net income attributable to common stockholders
-138.17%-9.89M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
-16.64%-22.26M
1.11%-6.62M
Basic earnings per share
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
Diluted earnings per share
-83.33%-0.44
-15.38%-0.3
-8.00%-0.27
22.38%-1.11
12.20%-0.36
35.14%-0.24
31.58%-0.26
7.41%-0.25
5.30%-1.43
14.58%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 78.80%7.79M42.04%6.6M26.66%5.57M-13.32%19.85M-6.07%6.45M-29.21%4.36M-19.56%4.64M7.19%4.4M19.04%22.9M1.30%6.87M
Selling and administrative expenses 31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M
-General and administrative expense 31.17%2.02M75.41%2.98M8.76%1.89M-7.82%6.93M-24.91%1.95M-7.89%1.54M12.58%1.7M0.12%1.74M25.14%7.52M9.24%2.6M
Research and development costs 104.82%5.77M22.77%3.61M38.35%3.68M-16.01%12.92M5.42%4.5M-37.16%2.82M-30.95%2.94M12.38%2.66M16.28%15.38M-3.00%4.27M
Operating profit -78.80%-7.79M-42.04%-6.6M-26.66%-5.57M13.32%-19.85M6.07%-6.45M29.21%-4.36M19.56%-4.64M-7.19%-4.4M-19.04%-22.9M-1.30%-6.87M
Net non-operating interest income expense 61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K
Non-operating interest income 61.17%332K21.40%261K4.89%236K32.97%847K-17.62%201K-25.63%206K235.94%215K332.69%225K327.52%637K197.56%244K
Other net income (expense)
Income before tax -79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M
Income tax
Net income -79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M
Net income continuous Operations -79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M
Minority interest income
Net income attributable to the parent company -79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M
Preferred stock dividends
Other preferred stock dividends 2.43M0
Net income attributable to common stockholders -138.17%-9.89M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M-16.64%-22.26M1.11%-6.62M
Basic earnings per share -83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.41
Diluted earnings per share -83.33%-0.44-15.38%-0.3-8.00%-0.2722.38%-1.1112.20%-0.3635.14%-0.2431.58%-0.267.41%-0.255.30%-1.4314.58%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More